Puma Biotechnology Inc - Asset Resilience Ratio

Latest as of December 2025: 31.39%

Puma Biotechnology Inc (PBYI) has an Asset Resilience Ratio of 31.39% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore Puma Biotechnology Inc asset portfolio for the complete picture of this company's asset base.

Liquid Assets

$67.90 Million

Cash + Short-term Investments

Total Assets

$216.30 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Puma Biotechnology Inc's Asset Resilience Ratio has changed over time. See PBYI equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Puma Biotechnology Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PBYI stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$67.90 Million	31.39%
Total Liquid Assets	$67.90 Million	31.39%

Asset Resilience Insights

Very High Liquidity: Puma Biotechnology Inc maintains exceptional liquid asset reserves at 31.39% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Puma Biotechnology Inc Industry Peers by Asset Resilience Ratio

Compare Puma Biotechnology Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Royalty Pharma Plc NASDAQ:RPRX	Biotechnology	0.11%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%
Hyundai Bioscience Co. Ltd KQ:048410	Biotechnology	13.57%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	82.25%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%

Annual Asset Resilience Ratio for Puma Biotechnology Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Puma Biotechnology Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	31.39%	$67.89 Million	$216.30 Million	+16.51pp
2024-12-31	14.88%	$31.75 Million	$213.33 Million	+9.96pp
2023-12-31	4.93%	$11.35 Million	$230.53 Million	+2.73pp
2022-12-31	2.19%	$4.87 Million	$222.06 Million	-6.18pp
2021-12-31	8.37%	$18.98 Million	$226.59 Million	+5.06pp
2020-12-31	3.32%	$8.10 Million	$244.22 Million	-18.65pp
2019-12-31	21.97%	$51.61 Million	$234.91 Million	-0.03pp
2018-12-31	22.00%	$57.00 Million	$259.12 Million	--
2017-12-31	0.00%	$0.00	$165.53 Million	--
2016-12-31	13.85%	$35.00 Million	$252.79 Million	-63.00pp
2015-12-31	76.84%	$184.30 Million	$239.84 Million	+13.68pp
2014-12-31	63.16%	$102.80 Million	$162.76 Million	+23.97pp
2013-12-31	39.19%	$40.90 Million	$104.37 Million	--
2012-12-31	0.00%	$0.00	$151.70 Million	--
2011-12-31	0.00%	$0.00	$55.40 Million	--

pp = percentage points

About Puma Biotechnology Inc

NASDAQ:PBYI USA Biotechnology

Market Cap

$371.91 Million

Market Cap Rank

#14024 Global

#3264 in USA

Share Price

$7.31

Change (1 day)

+0.55%

52-Week Range

$3.07 - $7.80

All Time High

$132.45